Jun 07, 2026
Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough
Pfizer (PFE) stock climbed 1.36% on strong obesity drug data showing 15% weight loss, a $10.5B cancer deal, and vaccine trials amid patent expiration concerns.
The post Pfizer (PFE) Stock Gains Ground on Once-Monthly Obesity Drug Breakthrough appeared first on Blockonomi.
Source: Blockonomi →Related News
- 37 minutes ago
Microsoft (MSFT) Stock: Chevron Partnership Powers AI Data Center Expansion Stra...
- 44 minutes ago
IBM (IBM) Stock Surges 4% on JPMorgan Upgrade and Presidential Quantum Support
- 45 minutes ago
Intel (INTC) Stock Receives $160 Price Target as BofA Sees Strengthening Fundame...
- 51 minutes ago
Tesla (TSLA) Stock Under Scrutiny as NHTSA Probes Deadly FSD Crash in Texas
- 52 minutes ago
SoFi (SOFI) Stock: New AI Investment Platform Composer Debuts for Retail Investo...